Press Releases

FALLS CHURCH, Va., Dec. 5, 2019 /PRNewswire/ -- December can be a difficult time for families spending their first holiday without a loved one. For those who've suffered loss—whether recently, or even years prior—the holiday stress can make the season more difficult. To help those grieving in Maryland, D.C., and

PROSPECT PARK, N.J., Dec. 5, 2019 /PRNewswire/ -- The Passaic Valley Water Commission (PVWC) is continuing to take aggressive steps to tackle lead concerns. Water quality is a huge topic around the country in the wake of Flint, Michigan and Newark, New Jersey. 

SAN FRANCISCO, Dec. 5, 2019 /PRNewswire/ -- Sequoia Living, a non-profit organization that offers housing and services to seniors in Northern California, rec

AUCKLAND, New Zealand, Dec. 5, 2019 /PRNewswire/ -- The science behind a breakthrough weight management extract invented in New Zealand has been proven in a study just-published in the scientific journal Nutrients.Amarasate™ is a world-first product that uses a New Zealand-grown bitter

SANDY, Utah, Dec. 5, 2019 /PRNewswire/ -- Central Logic, the industry innovator in enterprise visibility and tools to accelerate access to care, has announced that 30-year healthcar

SILVER SPRING, Md., Dec. 5, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the global launch of

BETHESDA, Md., Dec. 5, 2019 /PRNewswire/ -- Across the U.S., hundreds of hospitals are utilizing Nozin® Nasal Sanitizer® antiseptic to improve patient care and reduce healthcare costs. Five major hospitals presented clinical evidence of lower costs and reduced methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAIs)

BOSTON, Dec. 5, 2019 /PRNewswire/ -- The Agency for Healthcare Research and Quality (AHRQ) today announced the release of a publication addressing interoperability in r

PALM BEACH, Florida, Dec. 5, 2019 /PRNewswire/ -- For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs—given out only for therapies that have sho

BARCELONA, Spain, Dec. 5, 2019 /PRNewswire/ -- Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers, today announced the launch of its latest sterile compounding technology, KIRO Fill®